Cargando…
Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
BACKGROUND: Limb-girdle muscular dystrophy (LGMD) is a rare neuromuscular disease including a growing and heterogeneous number of subtypes with variable phenotype. Their clinical and histopathological characteristics frequently overlap with other neuromuscular dystrophies. Our goal was to identify,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793535/ https://www.ncbi.nlm.nih.gov/pubmed/36575500 http://dx.doi.org/10.1186/s13023-022-02603-3 |
_version_ | 1784859863238574080 |
---|---|
author | García-Giménez, José Luis García-Trevijano, Elena R. Avilés-Alía, Ana I. Ibañez-Cabellos, José Santiago Bovea-Marco, Miquel Bas, Teresa Pallardó, Federico V. Viña, Juan R. Zaragozá, Rosa |
author_facet | García-Giménez, José Luis García-Trevijano, Elena R. Avilés-Alía, Ana I. Ibañez-Cabellos, José Santiago Bovea-Marco, Miquel Bas, Teresa Pallardó, Federico V. Viña, Juan R. Zaragozá, Rosa |
author_sort | García-Giménez, José Luis |
collection | PubMed |
description | BACKGROUND: Limb-girdle muscular dystrophy (LGMD) is a rare neuromuscular disease including a growing and heterogeneous number of subtypes with variable phenotype. Their clinical and histopathological characteristics frequently overlap with other neuromuscular dystrophies. Our goal was to identify, by a non-invasive method, a molecular signature including biochemical and epigenetic parameters with potential value for patient prognosis and stratification. RESULTS: Circulating miRNome was obtained by smallRNA-seq in plasma from LGMD patients (n = 6) and matched-controls (n = 6). Data, validated by qPCR in LGMD samples, were also examined in other common muscular dystrophies: Duchenne (DMD) (n = 5) and facioscapulohumeral muscular dystrophy (FSHD) (n = 4). Additionally, biochemical and clinical parameters were analyzed. miRNome analysis showed that thirteen differentially expressed miRs could separate LGMD vs control group by hierarchical clustering. Most of differentially expressed miRs in LGMD patients were up-regulated (miR-122-5p, miR-122b-3p, miR-6511a-3p, miR-192-5p, miR-574-3p, mir-885-3p, miR-29a-3p, miR-4646-3p, miR-203a-3p and miR-203b-5p) whilst only three of sequenced miRs were significantly down-regulated (miR-19b-3p, miR-7706, miR-323b-3p) when compared to matched controls. Bioinformatic analysis of target genes revealed cell cycle, muscle tissue development, regeneration and senescence as the most affected pathways. Four of these circulating miRs (miR-122-5p, miR-192-5p, miR-19b-3p and miR-323b-3p), together with the myomiR miR-206, were further analysed by qPCR in LGMD, DMD and FSHD. The receiver operating characteristic curves (ROC) revealed high area under the curve (AUC) values for selected miRs in all groups, indicating that these miRs have good sensitivity and specificity to distinguish LGMD, DMD and FSHD patients from healthy controls. miR-122-5p, miR-192-5p and miR-323-3p were differentially expressed compared to matched-controls in all groups but apparently, each type of muscular dystrophy showed a specific pattern of miR expression. Finally, a strong correlation between miRs and biochemical data was only found in LGMD patients: while miR-192-5p and miR-122-5p negatively correlated with CK, miR-192-5p positively correlated with vitamin D3 and ALP. CONCLUSIONS: Although limited by the small number of patients included in this study, we propose here a specific combination of circulating miR-122-5p/miR-192-5p/miR-323-3 and biochemical parameters as a potential molecular signature whose clinical value for LGMD patient prognosis and stratification should be further confirmed in a larger cohort of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02603-3. |
format | Online Article Text |
id | pubmed-9793535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97935352022-12-28 Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies García-Giménez, José Luis García-Trevijano, Elena R. Avilés-Alía, Ana I. Ibañez-Cabellos, José Santiago Bovea-Marco, Miquel Bas, Teresa Pallardó, Federico V. Viña, Juan R. Zaragozá, Rosa Orphanet J Rare Dis Research BACKGROUND: Limb-girdle muscular dystrophy (LGMD) is a rare neuromuscular disease including a growing and heterogeneous number of subtypes with variable phenotype. Their clinical and histopathological characteristics frequently overlap with other neuromuscular dystrophies. Our goal was to identify, by a non-invasive method, a molecular signature including biochemical and epigenetic parameters with potential value for patient prognosis and stratification. RESULTS: Circulating miRNome was obtained by smallRNA-seq in plasma from LGMD patients (n = 6) and matched-controls (n = 6). Data, validated by qPCR in LGMD samples, were also examined in other common muscular dystrophies: Duchenne (DMD) (n = 5) and facioscapulohumeral muscular dystrophy (FSHD) (n = 4). Additionally, biochemical and clinical parameters were analyzed. miRNome analysis showed that thirteen differentially expressed miRs could separate LGMD vs control group by hierarchical clustering. Most of differentially expressed miRs in LGMD patients were up-regulated (miR-122-5p, miR-122b-3p, miR-6511a-3p, miR-192-5p, miR-574-3p, mir-885-3p, miR-29a-3p, miR-4646-3p, miR-203a-3p and miR-203b-5p) whilst only three of sequenced miRs were significantly down-regulated (miR-19b-3p, miR-7706, miR-323b-3p) when compared to matched controls. Bioinformatic analysis of target genes revealed cell cycle, muscle tissue development, regeneration and senescence as the most affected pathways. Four of these circulating miRs (miR-122-5p, miR-192-5p, miR-19b-3p and miR-323b-3p), together with the myomiR miR-206, were further analysed by qPCR in LGMD, DMD and FSHD. The receiver operating characteristic curves (ROC) revealed high area under the curve (AUC) values for selected miRs in all groups, indicating that these miRs have good sensitivity and specificity to distinguish LGMD, DMD and FSHD patients from healthy controls. miR-122-5p, miR-192-5p and miR-323-3p were differentially expressed compared to matched-controls in all groups but apparently, each type of muscular dystrophy showed a specific pattern of miR expression. Finally, a strong correlation between miRs and biochemical data was only found in LGMD patients: while miR-192-5p and miR-122-5p negatively correlated with CK, miR-192-5p positively correlated with vitamin D3 and ALP. CONCLUSIONS: Although limited by the small number of patients included in this study, we propose here a specific combination of circulating miR-122-5p/miR-192-5p/miR-323-3 and biochemical parameters as a potential molecular signature whose clinical value for LGMD patient prognosis and stratification should be further confirmed in a larger cohort of patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02603-3. BioMed Central 2022-12-27 /pmc/articles/PMC9793535/ /pubmed/36575500 http://dx.doi.org/10.1186/s13023-022-02603-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research García-Giménez, José Luis García-Trevijano, Elena R. Avilés-Alía, Ana I. Ibañez-Cabellos, José Santiago Bovea-Marco, Miquel Bas, Teresa Pallardó, Federico V. Viña, Juan R. Zaragozá, Rosa Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title | Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title_full | Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title_fullStr | Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title_full_unstemmed | Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title_short | Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies |
title_sort | identification of circulating mirnas differentially expressed in patients with limb-girdle, duchenne or facioscapulohumeral muscular dystrophies |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793535/ https://www.ncbi.nlm.nih.gov/pubmed/36575500 http://dx.doi.org/10.1186/s13023-022-02603-3 |
work_keys_str_mv | AT garciagimenezjoseluis identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT garciatrevijanoelenar identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT avilesaliaanai identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT ibanezcabellosjosesantiago identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT boveamarcomiquel identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT basteresa identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT pallardofedericov identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT vinajuanr identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies AT zaragozarosa identificationofcirculatingmirnasdifferentiallyexpressedinpatientswithlimbgirdleduchenneorfacioscapulohumeralmusculardystrophies |